论文部分内容阅读
目的:对急性脑血管病患者血液同型半胱氨酸进行测定,研究其对急性脑血管病的发病、诊断、预后等的作用及应用价值。方法:对急性脑血管病不同病情和病期的血液同型半胱氨酸进行动态观察。结果:急性脑血管病患者血液同型半胱氨酸为13.57±5.94μmol/L,显著高于正常对照组的9.32±3.41μmol/L(P<0.01)。结论:对急性脑血管病患者血液同型半胱氨酸的测定,有助于该病的诊断及预后的估计。
OBJECTIVE: To determine the plasma homocysteine level in patients with acute cerebrovascular disease and to study its effect on the pathogenesis, diagnosis and prognosis of acute cerebrovascular disease. Methods: The blood homocysteine in different stages and stages of acute cerebrovascular disease was observed dynamically. Results: The blood homocysteine in patients with acute cerebrovascular disease was 13.57 ± 5.94μmol / L, which was significantly higher than that of the normal control group (9.32 ± 3.41μmol / L, P <0.01). Conclusion: The determination of blood homocysteine in patients with acute cerebrovascular disease is helpful to the diagnosis and prognosis of the disease.